![Øyvind Sverre Bruland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Øyvind Sverre Bruland
Oprichter bij
Artbio, Inc.
Profiel
Øyvind Sverre Bruland is the founder of Algeta ASA, founded in 1997.
Dr. Bruland is the founder of Oncoinvent ASA, founded in 2007.
Dr. Bruland is the founder of Nordic Nanovector ASA, founded in 2009.
Dr. Bruland was the founder of Oncoinvent ASA (Old), founded in 2010, and held the title of Director.
Dr. Bruland is the founder of Artbio, Inc., founded in 2021, and holds the title of Chairman-Scientific Advisory Board.
Currently, Dr. Bruland holds the position of Professor at the University of Oslo.
Actieve functies van Øyvind Sverre Bruland
| Bedrijven | Functie | Begin |
|---|---|---|
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Artbio, Inc.
 Artbio, Inc. Hospital/Nursing ManagementHealth Services Provides redefining cancer care services | Oprichter | 01-01-2021 |
Eerdere bekende functies van Øyvind Sverre Bruland
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOINVENT ASA | Oprichter | - |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Oprichter | - |
| THOR MEDICAL | Oprichter | - |
| ALGETA ASA | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
29
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
Artbio, Inc.
Artbio, Inc. Hospital/Nursing ManagementHealth Services Provides redefining cancer care services | Health Services |
